STOCKS TELEGRAPH

Author: Mahrukh Rehan

  • Nextdoor Holdings, Inc. (KIND) stock is rising in aftermarket – Let’s see why?

    Nextdoor Holdings, Inc. (KIND) stock is rising in aftermarket – Let’s see why?

    Nextdoor Holdings, Inc. (KIND) experienced an increase of 11.65% in aftermarket following the update in SEC filing. However, the last trading session closed at $4.98 with a decrease of 9.78%.

    Holiday decorations and displays by KIND– What’s going on?

    KIND announced on 1st December 2021 that Nextdoor partnered with The Home Depot to create the Cheer Map, which shows nearby retail locations where neighbors can easily purchase whatever they need to make the holidays enjoyable, festive, and low-stress. From stunning decors to fantastic gift ideas on your list, there’s something for everyone. For the first time, the companies have put a holiday how-to guide on the map, complete with decorating ideas and gift suggestions.

    KIND and Veterans United Team Up – Will it work?

    On 11th November 2021, KIND announced the collaboration with Veterans United Home Loans to promote Veteran and military communities by assisting Veterans in becoming homeowners. Together, the mission-driven firms are starting local Proud Veteran Homeowner Nextdoor Groups in communities around the country to bring together Veterans and families to speak up, exchange ideas and advice, connect, donate, and plan events.

    Now what?

    KIND is delighted to partner with Nextdoor. It is a firm that aims to guarantee that all neighbors have a good community, as Veterans United helps Veterans become homeowners. It’s especially appropriate that the company announces this cooperation as the company honors Veterans, who are often the pillars of the communities in which they live. Last but not the least, the company will keep developing meaningful methods for Veterans to engage with one another and their neighbors, both online and in-person, as a result of this collaboration.

    About KIND

    Nextdoor is a platform that allows you to connect with communities that matter to you. The company’s goal is to create a society that is kinder, where everyone has a safe and supportive community. Every day, neighbors all over the world use Nextdoor to acquire trusted information, provide and receive help, and make real-world connections with individuals in their immediate vicinity. In addition, KIND feels that it is a basic human yearning to connect with others. Since its inception, Nextdoor has been guided by this truth and the fact that neighborhoods are among the most significant communities in life.

  • Orchard Therapeutics plc (ORTX) stock is jumping to 11.43% – Here’s why?

    Orchard Therapeutics plc (ORTX) stock is jumping to 11.43% – Here’s why?

    Orchard Therapeutics plc (ORTX) has seen an increase of 11.43% in the aftermarket because the company announced an agreement with National Health Service. However, the last trading session concluded at $1.05 with a decrease of 3.67%.

    Agreement of ORTX with National Health Service – What’s happening?

    ORTX announced on 3rd February 2022 that it has made an agreement with National Health Service. The agreement is based on evaluation determination from the National Institute for Health and Care Excellence (NICE), which will recognize Libmeldy’s clinical impact and economic value. In addition, the business reported the first two commercially treated patients in Germany and France who were able to take advantage of early access reimbursement arrangements. Lastly, a third Middle Eastern patient was referred to an Italian hospital for international paid therapy.

    Publication in The Lancet – What is it?

    On 21st January 2022, ORTX reported the publication of long-term clinical results testing the safety and efficacy of Libmeldy in The Lancet. The treatment with Libmeldy resulted in persistent, clinically important benefits in patients with developmental MLD. Moreover, these are encouraging findings that demonstrate the potential of the HSC gene therapy technique to treat severe genetic disorders with a particular procedure. Lastly, the company is launching Libmeldy throughout Europe and plans to pursue regulatory permissions in the future.

    What’s Next?

    Libmeldy is a game-changer in the therapy of MLD. These findings underscore the potential long-term advantages of HSC gene therapy for children, particularly when treatment is initiated before symptoms appear.

    Commercial and Regulatory Progress for HSC Gene Therapy Programs by ORTX

    On 10th January 2022, ORTX stated the commercial and regulatory progress of gene therapy programs at the virtual 40th Annual J.P. Morgan Healthcare Conference. Looking back on 2021, Orchard has made a lot of progress, from showing improvement with the release of Libmeldy in Europe to gaining clarity from regulators on the possible route forward for the MLD, WAS, and MPS-IH programs.

    Not only this but the company has also worked on displaying major discovery initiatives through the HAE partnership with Pharming. Lastly, ORTX is starting 2022 with the same passion and dedication to continue growing a firm focused on transforming the medical paradigm for patients with severe genetic illnesses.

  • Unity Software Inc. (U) is on a boost to 15.09% – What’s driving it high?

    Unity Software Inc. (U) experienced an increase of 15.09% in aftermarket following the announcement of the fourth quarter and full-year 2021 results. However, the last trading session closed at $92.54 with a decrease of 9.28%.

    Unity Software Inc. (U): Fourth Quarter and Full Year 2021 Results

    U announced fourth-quarter and full-year results on 3rd February 2022. The company reported revenue of $315.9 million with an incline of 43%. Moreover, strategic partnerships revenue came out to be $21.3 million. Not only this but non-GAAP loss from operations totaled $12.0 million. Furthermore, the cash and cash equivalents are $1.1 billion.

    Unity Software Inc. (U): How was the quarter?

    The Unity teams’ extraordinary execution and innovation drove the company’s great fourth-quarter and full-year performance. Moreover, the company feels that the shift from linear 2D to interactive real-time 3D represents significant opportunities for the next several decades.

    In addition, the performance in 2021 has been encouraging, with favorable performance across Create and Operate Solutions. Not only this but U is confident that, as they continue to enhance margins, they will be able to guide to a revenue growth range of 34 percent to 36 percent in 2022. Thanks to the strength of the commercial momentum and the quality of the development plans.

    Access to Meta Audience Network – All About it

    On 16th December 2021, U reported that the meta audience networks can be accessed easily through Unity Mediation. The Meta Audience Network is the newest addition to Unity Mediation, a suite of technologies that provide builders with exposure to some of the most extensive demand, including over 60+ ad ecosystem partners and improved capabilities for pricing strategies, competitive bidding, and total ad fill. Meta Audience Network and Unity embrace a mission of providing increased advantage and visibility to in-app developers on a worldwide scale. With this integration, developers will have easier access to high-quality demand, allowing them to optimize their earnings with better efficiency.

    So what?

    This agreement with Meta Audience Network will provide Unity Ads, developers of all sizes, with vital access to one of the industry’s major bidders. In addition, the main objective is to ensure the success of the developers, and with this relationship, they are providing a standardized approach to maximizing revenue potential. This is an important step in ensuring that publishers have the tools they need to improve operational and financial efficiency.

  • Lannett Company, Inc. (LCI) stock is going down in aftermarket – Here’s why?

    Lannett Company, Inc. (LCI) has seen a decrease of 19.72% in the aftermarket because the company announced fiscal 2022 second-quarter results. However, the last trading session closed at $1.42 with a decrease of 1.39%.

    Fiscal 2022 Second Quarter Results – Revealed by LCI!

    LCI announced fiscal 2022 second-quarter results on 3rd February 2022. The company experienced net sales of $86.5 million with gross profit that came out to be around $5.7 million. Not only this but the adjusted interest expense rose to $12.9 million. The negative adjusted EBITDA totaled $1.0 million. Last but not the least, the net loss reported was $81.1 million as compared to the $171.9 million from fiscal 2021.

    What’s Next?

    Net sales and gross margin were adversely affected during the quarter. It was due to continued and increasingly competitive pricing pressure across the product portfolio. While LCI expects this price environment to endure in the short term, the company is continuing to implement the basic strategy to expand the product pipeline, develop durable insulin and respiratory assets, and minimize costs across the board.

    Thinking forwards, the company has reduced the guidelines to reflect, among other things, a specific product optimal control effort, a postponement in the expected launch of a product line, considerably fewer supply requests expected for the rest of the year, and the competitive landscape for an amount of the oral similar medicines, as well as the aforementioned competitive environment. Lastly, LCI has a strong cash position of over $98 million as of December 31, 2021.

    Review of Investigational New Drug by LCI– What is it?

    LCI announced on 21st January 2022 that they have received the notification from FDA about the completion of the review of the Investigational New Drug (IND) application for biosimilar insulin glargine. The company is on schedule to start dosing individuals later this quarter. If the research is effective, LCI plans to file a Biologics License Application (BLA) in early 2023. Not only this but if everything went smooth, they might start the marketing of their product in early 2024. Moreover, Biosimilar insulin glargine is a vital product in the long-term development pipeline, and the company is excited to provide this critical biosimilar medicine to diabetic patients.

  • Bill.com Holdings, Inc. (BILL) stock is jumping high to 29.05% – What’s up?

    Bill.com Holdings, Inc. (BILL) stock experienced an increase of 29.05% in aftermarket following the announcement of second-quarter fiscal 2022 results. However, the last trading session closed at $170.28 with a decrease of 7.79%.

    Second Quarter Fiscal 2022 Financial Results – Latest News by BILL

    BILL announced second-quarter fiscal 2022 results on 3rd February 2022. The company reported revenue of about $156.5 million with an incline of 190%. Moreover, core revenue increased by 197% and reached $155.5 million. Not only this but the gross profit totaled $122.1 million and loss from operations came out to be $76.1 million. Last but not the least, the net loss reported was around  $80.4 million.

    Now what?

    BILL is really delighted with the significant revenue growth in the second quarter, particularly organic core revenue growth of 85% year over year and Divvy spend management revenue growth of 188%. The stats show that the company’s revenue has increased year-over-year. In addition, the company has also noticed increased gross margin and continued to improve efficiencies during the quarter, resulting in a non-GAAP net loss that was lesser than planned.

    Appointment of Germaine Cota by BILL – Worth it?

    BILL stated on 24th January 2022 that Germaine Cota has been appointed as the Senior Vice President, Finance & Accounting. The company is happy to have Germaine join the Bill.com team and help them achieve the goal of making mergers easy for small businesses to connect and do business Officer. Not only this but Germaine’s technical expertise, track record of scaling high-performing teams, and leadership abilities will be invaluable to the company at this time of rapid expansion.

    Experienced Brand-Builder – New Hirings

    BILL reported on 2nd December 2021 that the company has hired Sarah Acton as the Chief marketing officer. Sarah most recently headed marketing and sales at Athos, where she promoted product acceptance among major professional leagues, premier collegiate teams, and critical Department of Defense programs. She has a lot of marketing expertise gained from establishing worldwide brands in both the corporate and consumer markets. Lastly, the company welcomes Sarah to Bill.com, where she will help the team to expand the marketing and branding initiatives.

  • Aurora Innovation, Inc. (AUR) stock is on a boost in premarket – Here is the reason why?

    Aurora Innovation, Inc. (AUR) experienced an increase of 10.16% in premarket following the update in SEC filing. However, the last trading session closed at $4.92 with a decrease of 1.06%.

    Fourth Quarter and Full Year 2021 – When will it be released?

    AUR reported on 26th January 2022 that the company will announce fourth-quarter and full-year results on 16th February 2022. The results will be discussed via conference call at 5:00 p.m. Eastern Time.

    Product Milestones – What’s the update?

    AUR announced on 19th January 2022 that Aurora being a self-driving business is developing a device that will save lives, improve transit accessibility, and provide much-needed respite and support to supply chains. Moreover, the Aurora Driver will be developed in conditions that are economically relevant. Furthermore, Aurora is establishing the industry’s first large-scale autonomous trucking and ride-hailing business by investing early in underlying technologies and key programs that accelerate growth.

    Appointment of Claire Hughes Johnson by AUR – Worth it?

    AUR announced the appointment of Claire Hughes Johnson on 18th January 2022. Johnson has over 15 years of experience scaling companies and delivering enterprise-ready products at major firms such as Stripe and Google. Moreover, Johnson is presently a business officer and advisor for Stripe, a global financial technology firm where she has worked for the past seven years. From 2014 until 2021, Johnson was the Chief Operating Officer at Stripe, where she helped the company grow from under 200 workers to over 6,000 and from tens of millions to billions in sales.

    In addition, Claire understands how to grow enterprises and lead companies that are aiming to disrupt the existing quo. As AUR develops the operations, collaborates with partners and customers, and markets the Aurora Driver, her autonomous and forward-thinking approach will be vital.

    Expansion of Finance Team – Latest News by AUR

    AUR stated on 6th December 2021 that the company is expanding its finance team. Increasing its capacity to commercialize its self-driving technologies. Richard Tame has been appointed as the business’s Chief Financial Officer. Tame has far more than 2 decades of expertise in corporate accounting. He is also responsible for running financial institutions at high-growth firms such as Lyft, Facebook, Microsoft, and Amazon. Moreover, Richard’s vision and financial acumen have guided the company through many acquisitions and expansions. Richard’s appointment as CFO acknowledges the critical role he and his team have played and will continue to play as the company market the goods.

  • GWG Holdings, Inc. (GWGH) stock is experiencing decrease of 10.67% – More About it

    GWG Holdings, Inc. (GWGH) has seen a decrease of 10.67% in pre-market. However, the last trading session closed at $4.50 with an increase of 31.58%.  The recent decline can be attributed to investors’ profit takings.

    Requirement Completion for Listing on Nasdaq stock market

    GWGH announced on 30th December 2021 that Nasdaq has confirmed that it is in accordance with Nasdaq Listing Rule 5620(a). Not only this but it is in accordance with the continuing listing criteria, and it will be listed on the Nasdaq Stock Market.

    Third Quarter and Full Year Results by GWGH – What’s the new update?

    GWGH reported third quarter and full-year financial and operating results on 8th December 2021. The company experienced a net loss of about $50.6 million and $169.9 million in the third quarter and full-year respectively. Moreover, in the third quarter, the life insurance portfolio has continued to provide policy benefits. Not only this but the company has realized $43.2 million from 26 life insurance policies.

    In the most recent financial statements, GWGH said that the company is a going concern with serious weaknesses in internal controls. Due to the recent loss of the ability to generate cash and repeated losses from operational processes the viable business disclosure suggests there is a serious question about the company’s capacity to achieve its economic immediate liabilities over the next 12 months.

    Successful Resolution of Nasdaq Delisting Notification of GWGH

    GWGH announced the successful resolution of the Nasdaq Delisting Notification on 7th September 2021. GWGH will remain listed on Nasdaq, subject to the firm filing current financial statements. In addition, the company thanks Nasdaq for taking the time to examine the appeal. And the team is certain that they will be able to meet the timeframes it has set. Lastly, this will allow the company to remain focused on the business plan and exciting opportunities ahead.

    About GWGH

    GWG Holdings, Inc. (GWGH) is a Dallas-based financial services company that specializes in marketplace solutions for investors. GWGH operates and controls a diversified selection of alternative assets. Moreover, this includes $1.9 billion in life insurance benefits and visibility to a varied and growing loan portfolio protected by 122 actively managed substitute investment funds, through its subsidiaries.

  • HeartBeam, Inc. (BEAT) stock has climbed to 12.20% – Learn why is this happening?

    HeartBeam, Inc. (BEAT) has seen a push of 12.20% in aftermarket following the announcement of a partnership with LIVMOR. However, the last trading session closed at $2.05 with a decrease of 5.96%.

    Partnership of BEAT with LIVMOR – What’s up?

    BEAT announced on 2nd February 2022 that it has entered into a partnership with LIVMOR. It is a digital health solutions firm that has partnered with BETA in order to create a HeartBeam-branded version of LIVMOR’s Halo+ FDA-cleared turnkey system for remote patient monitoring that connects doctors and patients. Moreover, the company will be able to reach the FDA submission deadline for the initial product. The product is an easy-to-use heart attack detection software solution for Emergency Department settings.

    Furthermore, LIVMOR has successfully built a patient-engaged remote monitoring system of crucial physiological indicators, which BEAT believes may be converted to work with the Emergency Department software solution to improve MI detection accuracy. In addition, LIVMOR’s regulatory experience is a valuable asset to the company as the team pursues FDA authorization for the HeartBeam Platform. Lastly, the team is excited to collaborate with the LIVMOR on getting the software ready for FDA submission later this year.

    Establishment of Scientific Advisory Board & Appointment of Michael Gibson

    On 27th January 2022, BEAT reported that the company has established a  Scientific Advisory Board and also appointed C. Michael Gibson as the Chairman of SAB. Dr. Gibson brings almost 3 decades of expertise in cardiology as a scientist. The company welcomes Mr. Gibson on account of the Board executives team.

    He is a valuable asset for BEAT because his scientific expertise will be invaluable in advancing the product development, which will include an ER solution for more accurate MI diagnosis and a comprehensive telehealth system for remote MI monitoring.

    Appointment of Chief Operating Officer by BEAT – Worth it?

    BEAT announced on 22nd December 2021 that Alan Baumel has been appointed as the Chief Operating Officer. Mr. Baumel has a background of product development, production, quality assurance, and regulatory affairs specialist with over 35 years of experience.

    BEAT is happy to be welcome Alan to the Company on behalf of the board of directors. Furthermore, Alan’s vast experience and industry understanding will be critical in hastening industrialization and FDA product development. Alan’s extensive experience, particularly with cardiac devices, makes him a perfect fit for the heart attack detection and monitoring system. Last but not the least, Alan will not only strengthen the fundamental management team but will also help the team to commercialize and scale the technology.

  • ZW Data Action Technologies Inc. (CNET) stock has experienced a downfall – What’s happening?

    ZW Data Action Technologies Inc. (CNET) experienced a decrease of 23.75% in aftermarket following the update that Meta earnings undergo disappointment as Facebook’s parent pushes into the metaverse. However, the last trading session closed at $0.80 with a decrease of 4.75%.

    Cooperation for NFT and Metaverse Market by CNET – What’s up?

    On 21st December 2021, CNET announced that it has collaborated with Guangzhou Digital Gold Information Technology Co., Ltd (Digital Gold Transformation). This agreement will be helpful in the development of IP+NFT products. Digital Gold Information is a firm committed to the creation of IP peripheral goods and IP business operations. Offline interaction and display, promotional strategies and co-branding, peripheral products, and digital merchandise are all part of its business. During this collaboration, the two parties will create the IP + NFT + Metaverse business model. This will be done by supplying peripheral items and digital commerce services for recognized IPs.

    What’s Next?

    NFT’s primary use cases rapidly broaden from bitcoin and games to collectibles, artwork, domain names, identification, and other sectors. CNET believes that IP + NFT + Metaverse will be a crucial implementation of the blockchain technology, as the interconnections of NFT with metaverse may be the future focus in the technology industry.

    Strategic Cooperation on Blockchain + Insurance by CNET 

    On 30th November 2021,  CNET reported that it has entered into a collaboration with Shanghai Weiyou Information Technology Co., Ltd. Certain “Blockchain + Insurance” services for small and medium-sized businesses are intended to be supplied through the Platform, adding to the insurance ecosystem by upgrading blockchain technology. Moreover, based on ZW Data’s blockchain technology, the two companies will collaborate to create and launch a cost-effective insurance platform.

    Furthermore, Weiyou Information will offer one-stop services through the Platform, ensuring that all connected insurance processes and data can be validated and tracked. Not only this but it will also help in enhancing transparency and credibility for all parties involved. Apart from Klover InsurTech’s present auto insurance, ZW Data and Weiyou Information will collaborate on additional forms of insurance product research and development. Meanwhile, in order to promote the Platform, the Company will work with a number of new media outlets.

    So what?

    Blockchain and other internet technologies are fast advancing and becoming a backbone in all industries. This will cause old corporate management models to be disrupted. The insurance business is projected to become a large and crucial market for blockchain implementation. Last but not the least, the company hopes that this collaboration will help CNET grow the blockchain-related services and technology in the long run.

  • Flex Ltd. (FLEX) stock is moving high to 8.54% in aftermarket – Latest News you should know!

    Flex Ltd. (FLEX) has seen a push of 8.54% in the aftermarket following the update of partnership with TPG Rise Climate. However, the last trading session closed at $16.75 with an increase of 2.26%.

    Partnership with TPG Rise Climate – Worth it?

    On 2nd February 2022, FLEX announced that PG Rise Climate, TPG’s focused climate investing strategy, has agreed to buy $500 million of convertible preferred shares in Nextracker. Moreover, TPG Rise Climate’s strategic relationship and investment will help Nextracker maintain its business status in solar tracking and management software. TPG’s knowledge and wide network in renewable energy make TPG an excellent partner for Nextracker’s long-term development.

    Furthermore, by formulating and delivering best-in-class product quality, technology, value, and flexibility, Nextracker has positioned itself to be a leader in the solar tracking industry. As solar installations proliferate in the United States and around the world, Nextracker is well-positioned to be solar developers’ and EPCs’ long-term monitoring provider of choice. Last but not the least, the company forwards to the profit maximization from combined resources, expertise, and skills.

    Appointment of Patrick J. Ward – Latest News by FLEX

    FLEX announced the appointment of Patrick J. Ward as a member of the Board of Directors on 27th January 2022. With an outstanding 30-year career as Chief Financial Officer, Mr. Ward resigned from Cummins Inc. and joined FLEX. He is here to serve with his amazing skills and capabilities. Pat Ward has a track record of success in the financial and executive realms. The company is sure that he will be a tremendous addition to the Board, therefore the company welcomes him warmly.

    Acquisition of Anord Mardix Completed – What’s happening?

    On 1st December 2022, FLEX announced that it has finalized the merger of Anord Mardix. This transaction will help Flex’s Industrial business to strengthen, which will add to Flex’s portfolio of power networks and extend its offerings in the quickly evolving data center industry. Moreover, the company is thrilled to finalize this deal and welcome the Anord Mardix team to Flex. Lastly, this purchase accelerates Flex’s transition to higher-margin areas of business while also bolstering the capacity to provide top data center power solutions to new and existing customers throughout the world.